Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study
Gustavo Saposnik(St. Michael's Hospital), Jiwon Oh(St. Michael's Hospital), M Foss, Tomáš Kalinčík(The Royal Melbourne Hospital), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Óscar Fernández(Universidad de Málaga), Heinz Wiendl(University Hospital Münster), Andreia Costa(Hospital de São João), Veronica Popescu(Hasselt University), H.J. Kim(National Cancer Center), E. Celius(University of Oslo), Maria Pia Amato(Don Carlo Gnocchi Foundation), Fei Zuo(St. Michael's Hospital), Sanketh Andhavarapu(St. Michael's Hospital), Fernando Cáceres(Instituto de Neurología Cognitiva), Eva Havrdová(Charles University), Melinda Magyari(University of Copenhagen), R. Bermel(Cleveland Clinic), María Terzaghi(St. Michael's Hospital)
Cited by 14
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k